WiNEX产品拓展较好，人效提升显著

Investment Rating - The report maintains a "Recommended" rating for the company [5]. Core Insights - The company's revenue for 2023 reached 3.163 billion, a year-on-year increase of 2.28%, while the net profit attributable to shareholders was 358 million, showing a significant growth of 229.49% [5]. - The healthcare information technology business saw a slight increase in new orders, with revenue growing by 12.66% to 2.849 billion in 2023 [6]. - The gross profit margin improved to 45%, up by 1.31 percentage points from the previous year, attributed to the increasing proportion of high-margin healthcare information technology revenue [7]. - The "1+X" strategy continues to evolve, with the WiNEX product line supporting high-quality development in hospital digital transformation [8]. Financial Performance Summary - In 2023, the company achieved a revenue of 3.163 billion, with a growth rate of 2.28% [11]. - The net profit attributable to shareholders was 358 million, reflecting a growth rate of 229.49% [11]. - The company expects revenues of 3.736 billion, 4.349 billion, and 4.907 billion for 2024, 2025, and 2026, respectively, with growth rates of 18.1%, 16.4%, and 12.8% [8]. - The projected net profit for the same years is 563 million, 716 million, and 857 million, with growth rates of 57.4%, 27.2%, and 19.6% [8].